Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 69.75M
June 30, 2026 61.68M
March 31, 2026 58.86M
December 31, 2025 58.82M
September 30, 2025 60.63M
June 30, 2025 63.11M
March 31, 2025 61.25M
December 31, 2024 55.16M
September 30, 2024 51.43M
June 30, 2024 46.61M
March 31, 2024 43.07M
December 31, 2023 42.36M
September 30, 2023 38.07M
June 30, 2023 34.10M
March 31, 2023 31.50M
December 31, 2022 28.38M
September 30, 2022 28.52M
June 30, 2022 27.58M
March 31, 2022 24.91M
June 30, 2021 23.28M
March 31, 2021 18.04M
December 31, 2020 11.42M
September 30, 2020 7.134M
June 30, 2020 3.003M
March 31, 2020 0.00
Date Value
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Iovance Biotherapeutics, Inc. 164.64M
Halozyme Therapeutics, Inc. 1.371B
Agenus, Inc. 131.74M
Amgen, Inc. 28.84B
Fate Therapeutics, Inc. -6.689M